Aaron M Etra, MD
Hematology-Oncology, Cancer (Oncology)
Aaron Etra, MD, is Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai and a member of The Tisch Cancer Institute. His clinical practice focus is on autologous and allogeneic stem cell transplantation for acute myeloid leukemia, myelodysplastic syndromes, acute lymphoblastic leukemia, bone marrow failure syndromes, lymphoma, and multiple myeloma. Dr. Etra provides evidence-based care that is compassionate and patient-centered.
Dr. Etra’s research interests include acute graft-versus-host disease (aGVHD), a primary cause of non-relapse mortality following allogeneic stem cell transplantation, and infectious complications post-transplant. He is a member of the Mount Sinai Acute GVHD International Consortium (MAGIC), which promotes development and testing of innovative treatment approaches for aGVHD.
Dr. Etra is an investigator on numerous clinical trials, including MAGIC observational studies and trials that investigate novel agents for both low-risk and high-risk GVHD. He is the site principal investigator at Mount Sinai for trials of the Blood and Marrow Transplant Clinical Trials Network that are focused on developing tools for predicting non-relapse mortality in transplant patients and identifying improved GVHD prophylaxis and treatment regimens.
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West